These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2150209)

  • 21. Effects of cromakalim, pinacidil and glibenclamide on cholinergic transmission in rat isolated atria.
    Fabiani ME; Story DF
    Pharmacol Res; 1995 Sep; 32(3):155-63. PubMed ID: 8745346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
    Triggle CR; Li YQ; Wyse DG
    Proc West Pharmacol Soc; 1992; 35():97-102. PubMed ID: 1502246
    [No Abstract]   [Full Text] [Related]  

  • 23. Vasodilatation of canine cerebral arteries by nicorandil, pinacidil and lemakalim.
    Zhang H; Stockbridge N; Weir B; Vollrath B; Cook D
    Gen Pharmacol; 1992 Mar; 23(2):197-201. PubMed ID: 1353469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T; Angus JA
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.
    Nagai H; Kitagaki K; Goto S; Suda H; Koda A
    Jpn J Pharmacol; 1991 May; 56(1):13-21. PubMed ID: 1831870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
    Imagawa J; Akima M; Nabata H; Taira N
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro.
    Wilson C
    J Auton Pharmacol; 1989 Feb; 9(1):71-8. PubMed ID: 2498342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil.
    Holzmann S; Kukovetz WR; Braida C; Pöch G
    Eur J Pharmacol; 1992 Apr; 215(1):1-7. PubMed ID: 1325362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.
    Kreye VA; Lenz T; Theiss U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):70-5. PubMed ID: 1827659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.
    Masuzawa K; Matsuda T; Asano M
    Br J Pharmacol; 1990 May; 100(1):143-9. PubMed ID: 2115387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA; Stork AP
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potassium channel openers relax A23187-induced nifedipine-resistant contraction of rat aorta.
    Yamashita T; Masuda Y; Tanaka S
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):914-20. PubMed ID: 7898074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative inotropic effect of pinacidil on the rat left atria.
    Doggrell SA
    J Pharm Pharmacol; 1993 Nov; 45(11):1000-2. PubMed ID: 7908028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia.
    D'Alonzo AJ; Darbenzio RB; Hess TA; Sewter JC; Sleph PG; Grover GJ
    Cardiovasc Res; 1994 Jun; 28(6):881-7. PubMed ID: 7923295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relaxant effects of the potassium channel activators BRL 38227 and pinacidil on guinea-pig and human airway smooth muscle, and blockade of their effects by glibenclamide and BRL 31660.
    Buckle DR; Arch JR; Bowring NE; Foster KA; Taylor JF; Taylor SG; Shaw DJ
    Pulm Pharmacol; 1993 Mar; 6(1):77-86. PubMed ID: 8477155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
    J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by glibenclamide of negative chronotropic and inotropic responses to pinacidil, acetylcholine, and adenosine in the isolated dog heart.
    Murakami M; Furukawa Y; Karasawa Y; Ren LM; Takayama S; Chiba S
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):618-24. PubMed ID: 1380606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels.
    Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the in vitro effects of K+ channel modulators on detrusor and portal vein strips from guinea pigs.
    Zografos P; Li JH; Kau ST
    Pharmacology; 1992; 45(4):216-30. PubMed ID: 1438528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.